DJIA52347.55 50.46
S&P 5007561.67 -30.73
NASDAQ25136.27 -229.82
Russell 20002790.49 -8.57
German DAX26749.95 -21.93
FTSE 10010902.56 39.47
CAC 408368.91 7.55
EuroStoxx 506388.55 -13.20
Nikkei 22561142.35 322.99
Hang Seng23637.60 -370.95
Shanghai Comp3634.35 -21.48
KOSPI5290.53 -52.20
Bloomberg Comm IDX133.48 -0.40
WTI Crude-fut96.05 0.28
Brent Crude-fut88.85 -0.06
Natural Gas3.62 -0.13
Gasoline-fut2.63 -0.03
Gold-fut3887.60 1.90
Silver-fut48.65 -1.33
Platinum-fut1492.20 -26.60
Palladium-fut1000.00 7.00
Copper-fut6.06 -0.14
Aluminum-spot2995.00 0.00
Coffee-fut274.00 -1.10
Soybeans-fut1232.00 13.00
Wheat-fut593.00 11.00
Bitcoin68344.73 -2931.63
Ethereum USD1927.93 -83.57
Litecoin49.32 -0.69
Dogecoin0.06 0.00
EUR/USD1.1051 -0.0007
USD/JPY159.91 0.01
GBP/USD1.3230 -0.0004
USD/CHF0.8380 0.0030
USD IDX103.41 0.20
US 10-Yr TR5.139 0.036
GER 10-Yr TR3.3901 0.0127
UK 10-Yr TR5.3377 -0.0028
JAP 10-Yr TR2.872 0.011
Fed Funds4 0
SOFR3.9 0.01
High-rise commercial buildings

Latest News

Merchant Takes Minority Stake in Elevation Point, Expands Credit Facility

Financial Advisory  + RIAs & Financial Advisors  + Wealth Management  | 

Healthcare PE Breaks Record With $191B in 2025 as Venture Funding Recalibrates — Evening Brief – 01.16.26 

Global healthcare private equity reached a new peak in 2025, with deal value climbing to a record $191 billion, according to a new annual report from Bain & Company. The surge came even as healthcare venture capital continued to retrench from its post-pandemic highs, underscoring a clear divide between late-stage buyout activity and early-stage risk appetite. 

Taken together with Silicon Valley Bank’s 17th annual Healthcare Investments and Exits report, the data point to a maturing investment landscape: buyout firms are leaning into scale and consolidation, while venture investors are becoming more selective. 

Bain attributed the record year to a sharp increase in billion-dollar-plus transactions, with 445 healthcare buyouts announced—making 2025 the second-busiest year on record by deal count. Exit activity also rebounded meaningfully, with total exit value jumping to $156 billion from $54 billion in 2024, as sponsor-to-sponsor transactions recovered from a post-pandemic lull. 

“Healthcare private equity delivered a record performance last year as large deals spiked and deal count rose across all tiers,” said Kara Murphy, a partner at Bain and co-leader of its healthcare private equity practice. 

By sector, biopharma led the market with approximately $80 billion in deal value, up from $55 billion a year earlier. Provider services followed, rising 57% to $62 billion, while healthcare IT emerged as a standout, with deal value in the provider segment doubling to $32 billion. 

Venture capital activity moved in the opposite direction. Silicon Valley Bank reported $46.8 billion in healthcare VC investment in 2025, down 12% year over year and well below the $68.3 billion peak reached in 2021. Artificial intelligence dominated what capital was deployed, capturing 46% of all healthcare venture dollars, or more than $18 billion, driven by the funding needs of generative and agentic AI platforms. 

“Healthcare venture fundraising has entered a reset,” said Megan Scheffel, noting that investors are increasingly prioritizing clinical validation, revenue visibility, and capital efficiency. 

Geographically, private equity strength was broad-based. Europe’s healthcare deal value doubled to $59 billion, North America recorded 26 billion-dollar-plus deals, and Asia Pacific set a new regional record, surpassing its 2021 high by more than 30%. 

Looking ahead, Bain partner Nirad Jain cited ample dry powder and aging portfolio assets as tailwinds for 2026—while cautioning that competition will keep pressure on disciplined value creation. 

Connect

Inside The Story

About Joe Palmisano

Joe Palmisano is editorial director of Connect Money, where he oversees daily coverage of alternative assets, direct investments, financial advisory and the economy. He brings three decades of experience as a financial journalist, analyst and portfolio manager. Before joining Connect Money, Palmisano wrote for The Wall Street Journal, covering foreign exchange, global fixed-income and equity markets. He later served as a senior research analyst and portfolio manager, producing market analysis and managing foreign exchange and U.S. equity portfolios for FX Concepts. His work has also appeared in SFO Magazine and CMT Association publications. Palmisano earned a bachelor’s degree in finance from The American University and holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.